During the last decade, the push within the biotechnology and pharmaceutical industry has been three-fold as manufacturers look to increase capacity, gain flexibility, and decrease costs. How each of these needs are characterised depends on the scale and complexity of a production process. An increased capacity permits more product; greater flexibility allows plants to explore different processes; lesser outlay means higher profits and a greater opportunity for growth, research and development.
Each factor has led to the development and adoption of single-use systems (SUS). Where permanent, stainless steel systems have proven, for many years, to be robust and straightforward to maintain, the introduction of SUS has given biomanufacturers more choices when it comes to how they make their products.